These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. [Role of autoimmunity in multiple sclerosis]. Chabas D; Liblau R Pathol Biol (Paris); 2000 Feb; 48(1):25-46. PubMed ID: 10729910 [TBL] [Abstract][Full Text] [Related]
24. Cellular immunity in multiple sclerosis. Rysková O; Vejbora O; Chromová L; Pekárek J; Chmelar V; Zaydlar K Sb Ved Pr Lek Fak Karlovy Univerzity Hradci Kralove; 1981; 24(1):85-91. PubMed ID: 6975970 [No Abstract] [Full Text] [Related]
25. DNA damage: a trigger of innate immunity but a requirement for adaptive immune homeostasis. Xu Y Nat Rev Immunol; 2006 Apr; 6(4):261-70. PubMed ID: 16498454 [TBL] [Abstract][Full Text] [Related]
26. Theories of the etiology of multiple sclerosis: a critical review. Sayetta RB J Clin Lab Immunol; 1986 Oct; 21(2):55-70. PubMed ID: 3102746 [TBL] [Abstract][Full Text] [Related]
27. Cellular and humoral immune responses against autoreactive T cells in multiple sclerosis patients after T cell vaccination. Hermans G; Denzer U; Lohse A; Raus J; Stinissen P J Autoimmun; 1999 Sep; 13(2):233-46. PubMed ID: 10479392 [TBL] [Abstract][Full Text] [Related]
28. Isoprinosine in multiple sclerosis treatment: a preliminary study. Mazzarello P; Rocchelli B; Poloni M; Delodovici M; Pinelli P Schweiz Arch Neurol Neurochir Psychiatr; 1982; 131(2):175-9. PubMed ID: 6187064 [TBL] [Abstract][Full Text] [Related]
29. [Auto-immunity and multiple sclerosis]. Goudemand M Lille Med; 1973 Nov; 18(9):1149-57. PubMed ID: 4603354 [No Abstract] [Full Text] [Related]
30. Cell-mediated hypersensitivity and disease activity in multiple sclerosis. Sheremata W; Cosgrove JB; Robb P Trans Am Neurol Assoc; 1973; 98():306-9. PubMed ID: 4784962 [No Abstract] [Full Text] [Related]
31. Preparation of antisera directed against the idiotype(s) of immunoglobulin G from the cerebrospinal fluid of patients with multiple sclerosis. Nagelkerken LM; Aalberse RC; van Walbeek HK; Out TA J Immunol; 1980 Jul; 125(1):384-9. PubMed ID: 7381204 [No Abstract] [Full Text] [Related]
37. Bioelectromagnetic applications for multiple sclerosis. Richards TL; Lappin MS; Lawrie FW; Stegbauer KC Phys Med Rehabil Clin N Am; 1998 Aug; 9(3):659-74. PubMed ID: 9894116 [TBL] [Abstract][Full Text] [Related]
38. Reply to "'Thinking without thinking' about natalizumab and PML". Houff S; Berger JR J Neurol Sci; 2008 Jan; 264(1-2):198-9; author reply 199. PubMed ID: 17936798 [No Abstract] [Full Text] [Related]
39. Oligoclonal bands and antibody responses in multiple sclerosis. Correale J; de los Milagros Bassani Molinas M J Neurol; 2002 Apr; 249(4):375-89. PubMed ID: 11967640 [TBL] [Abstract][Full Text] [Related]
40. Idiotype vaccination against murine B cell lymphoma. Humoral and cellular responses elicited by tumor-derived immunoglobulin M and its molecular subunits. Campbell MJ; Carroll W; Kon S; Thielemans K; Rothbard JB; Levy S; Levy R J Immunol; 1987 Oct; 139(8):2825-33. PubMed ID: 3498771 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]